{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:42:05Z","timestamp":1773117725984,"version":"3.50.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of recombinant human growth hormone (rhGH) in children with JDM experiencing glucocorticoid (GC)-induced growth failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study included 16 refractory JDM patients treated with rhGH (0.10\u20130.15\u2009IU\/kg\/day) for 6\u201324\u2009months. Outcomes including height Z-score, growth velocity (GV), biochemical markers, disease activity and adverse events were recorded and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After 6\u2009months of rhGH treatment, the height Z-score improved from \u22122.37\u2009\u00b1\u20091.15 at baseline to \u22121.73\u2009\u00b1\u20091.06 (P\u2009&amp;lt;\u20090.001), and GV increased from 2.74\u2009\u00b1\u20091.53\u2009cm\/year to 13.05\u2009\u00b1\u20093.64\u2009cm\/year (P\u2009&amp;lt;\u20090.001). Serum insulin-like growth factor 1 and alkaline phosphatase levels rose significantly (from 264.13\u2009\u00b1\u200981.24\u2013351.59\u2009\u00b1\u2009123.41\u2009ng\/ml and 242.40\u2009\u00b1\u200942.25\u2013318.70\u2009\u00b1\u200986.12 U\/l, respectively; P\u2009&amp;lt;\u20090.05). Creatine kinase levels increased but remained within the normal range (from 79.33\u2009\u00b1\u200927.56\u2013111.60\u2009\u00b1\u200942.84 U\/l; P\u2009&amp;lt;\u20090.01). Only one patient (1\/16, 6.25%) experienced JDM relapse, a rate lower than the reported recurrence rate (31.6%) in JDM patients not receiving rhGH treatment\u200c. No adverse metabolic or endocrine effects were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In JDM patients with growth failure, rhGH therapy may be considered as a potential treatment option, supported by preliminary evidence. Our study suggests an acceptable safety profile and potential efficacy in improving growth parameters, even in refractory cases. Further larger-scale multicentre studies will be necessary to confirm its application value in JDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf236","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T07:38:10Z","timestamp":1750145890000},"page":"5611-5615","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of rhGH in juvenile dermatomyositis children with glucocorticoid-related growth failure"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4373-6061","authenticated-orcid":false,"given":"Xiaolei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Capital Center for Children\u2019s Health, Capital Medical University , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Capital Center for Children\u2019s Health, Capital Medical University , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baozhen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, City University of Hong Kong , Hong Kong,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Capital Institute of Pediatrics , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxu","family":"Ren","sequence":"additional","affiliation":[{"name":"Institute of Food and Nutrition Development, Ministry of Agriculture and Rural Affairs of the People\u2019s Republic of China , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Capital Center for Children\u2019s Health, Capital Medical University , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-2950","authenticated-orcid":false,"given":"Jianguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Capital Center for Children\u2019s Health, Capital Medical University , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"2025110820495609700_keaf236-B1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025110820495609700_keaf236-B2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJM195604052541402","article-title":"Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children","volume":"254","author":"Blodgett","year":"1956","journal-title":"N Engl J Med"},{"key":"2025110820495609700_keaf236-B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/acr.24065","article-title":"Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study","volume":"72","author":"Nordal","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025110820495609700_keaf236-B4","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2006-2877","article-title":"Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study","volume":"92","author":"Simon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2025110820495609700_keaf236-B5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2025110820495609700_keaf236-B6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/rheumatology\/keac399","article-title":"Long-term follow-up of Janus-kinase inhibitor and novel active disease biomarker in juvenile dermatomyositis","volume":"62","author":"Huang","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025110820495609700_keaf236-B7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.eprac.2022.04.004","article-title":"Pediatric continuous reference intervals of serum insulin-like growth factor 1 levels in a healthy Chinese children population\u2014based on PRINCE study","volume":"28","author":"Cao","year":"2022","journal-title":"Endocr Pract"},{"key":"2025110820495609700_keaf236-B8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.rdc.2021.07.003","article-title":"Updates on juvenile dermatomyositis from the last decade: classification to outcomes","volume":"47","author":"Kim","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"2025110820495609700_keaf236-B9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025110820495609700_keaf236-B10","first-page":"50","article-title":"Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis","volume":"23","author":"Ponyi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2025110820495609700_keaf236-B11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-014-2479-z","article-title":"Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome","volume":"174","author":"Ribeiro","year":"2015","journal-title":"Eur J Pediatr"},{"key":"2025110820495609700_keaf236-B12","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1210\/jcem.83.8.5036","article-title":"Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study","volume":"83","author":"Allen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2025110820495609700_keaf236-B13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/adc.2004.069138","article-title":"Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia","volume":"91","author":"Grote","year":"2006","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"2025110820495609700_keaf236-B14","first-page":"13","article-title":"Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects","volume":"56","author":"Mauras","year":"2001","journal-title":"Horm Res"},{"key":"2025110820495609700_keaf236-B15","first-page":"8421","article-title":"The effects of growth hormones on the growth velocities and serum index expressions in short stature children","volume":"13","author":"Zhou","year":"2021","journal-title":"Am J Transl Res"},{"key":"2025110820495609700_keaf236-B16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/annrheumdis-2012-201849","article-title":"Low serum levels of vitamin D in idiopathic inflammatory myopathies","volume":"72","author":"Azali","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025110820495609700_keaf236-B17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s004670050421","article-title":"Subclinical activation of lupus nephritis by recombinant human growth hormone","volume":"12","author":"Yap","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"2025110820495609700_keaf236-B18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00913847.2018.1406778","article-title":"The role of hormones in muscle hypertrophy","volume":"46","author":"Fink","year":"2018","journal-title":"Phys Sportsmed"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf236\/63519267\/keaf236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5611\/63519267\/keaf236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5611\/63519267\/keaf236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:50:04Z","timestamp":1762653004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/11\/5611\/8167899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,18]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf236","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,18]]}}}